Skip to content

The use of vitamin D supplementation and risk of hypercalciuria

evaluation of effect of Vitamin D supplementation on hypercalciuria in vitamin D deficient recurrent stone former patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180108038262N2
Enrollment
30
Registered
2018-08-10
Start date
2014-01-01
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: urolithiasis. Condition 2: vitamin D deficiency. Calculus of kidney and ureter Vitamin D deficiency, unspecified

Interventions

Intervention group: administration of vitamin D pearl 50000 unit weekly for 2 month and then every 2 weak until third month.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: urinary stone former vitamin D defficiency sign the constant form

Exclusion criteria

Exclusion criteria: pregnant patients hypercalcemia (baseline calcium level of =10.4 mg/dl) medications that affect calcium and bone metabolism (such as calcium) or calcium excretion (such as steroidal or hormonal drugs), previous history of primary hyperparathyroidism or other systemic diseases (cancer, alcoholic liver disease and osteoporosis) patients who had invasive diagnostic or therapeutic interventions on renal stones within the last month prior to enrollment known case of uric acid ,cysteine or steruvite urinary stone

Design outcomes

Primary

MeasureTime frame
Amount of increase in urinary calcium. Timepoint: before and after 3 month of vitamin D prescription. Method of measurement: measurement of calcium in 24 hour urine.;Urinary stone formation. Timepoint: 3 month after treatment. Method of measurement: ultrasound examination.

Secondary

MeasureTime frame
Serum parathyroid change. Timepoint: before and 3 month after vitamin D prescription. Method of measurement: laboratory measurment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Ganji

Tehran University of Medical Sciences

mrezaganji@yahoo.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026